Mint Press reported earlier this week on the “pay for delay” case that went before the Supreme Court for argument on Monday. As indicated in that report, drug companies pay manufactures of generic drugs to keep them off the market, with the result being the consumers pay more for their prescriptions. On the one hand, this can look like a
Pay for delay: The Patent Wars
In a Jan. 7, 2008, file photo then-Attorney Donald Verrilli talks to media outside the Supreme Court. Now President Barack Obama’s top Supreme Court lawyer, Solicitor General Verilli will argue before the Supreme Court this week whether it is legal for patent-holding pharmaceutical companies to pay rivals, who make generic drugs, to temporarily keep those […]